Scope the deployment against targets stated up front: fewer claims denials tied to patient education gaps, higher prior authorization completion because patients get clear explanations in their preferred language before they ever call the payer, and movement in the HCAHPS communication domains that feed CMS reimbursement under value-based care. Each of those has a baseline you already report on - set it before go-live and audit against it quarterly. The marketing capacity gain is the most immediate: the hours now going to manual translation and segmentation shift to campaign strategy and payer relationship work once the system does the drafting.
ROI compounds over 12 months as the system learns. The early months target the quick wins - denial reduction and prior auth speed - while months 4-8 compound as personalization gets more granular and the AI identifies which message variants drive appointment adherence, protecting downstream clinical revenue. The denial-recovery math should be built from your own volumes: take the denials your revenue cycle team tags to patient education gaps and price them at your average claim value. That number - not a vendor benchmark - is what the system is chasing. The free AI Opportunity Assessment is where that conversation starts: a directional read on where the opportunity is biggest, not a substitute for pricing it against your own data.